Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer

NCT02486198 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Neurotoxicity

Interventions

DRUG: placebo
DRUG: GM
DRUG: oxaliplatin-based chemotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital